High-performance invasive brain-computer interface nears clinical validation stage
According to Li, by working with Peking University First Hospital, Xuanwu Hospital Capital Medical University and Beijing Tiantan Hospital of the Capital Medical University, Neucyber Neurotech has finished five Beinao-1 implantation operations since the beginning of 2025, delivering motor and speech rehabilitation and functional substitution for individuals with spinal cord injuries, stroke, or amyotrophic lateral sclerosis.
Beinao-1 is the world's first high-throughput wireless fully implanted BCI system and is an electroencephalogram-based BCI system.
"Next, we will complete the official registered clinical trial for the Beinao-1 intelligent BCI system, continuing to advance technological optimization and application expansion, bringing hope to more patients," Li added.
- Where brands debut: First in Shanghai kicks off
- Shanghai blazes a unique path in becoming a global hub for the launch of products
- Expert: China's solutions to global AI governance prioritize inclusiveness
- South China Sea sub-forum calls for greater restraint, dialogue, cooperation to safeguard regional peace
- Blue Circle model offers China's solution for ocean governance
- Testing begins on the Shandong section of Xiong'an-Shangqiu high-speed railway
